Volume 74, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


We evaluated prescription and correct dosing of a 14-day course of dispersible zinc tablets prescribed to young children with diarrhea by community and facility workers in rural, southern Mali, West Africa. One hundred twenty-three children were followed at home on days 3 and 14 after being prescribed zinc. The age-appropriate dose of zinc was dispensed in 94% of cases. Ninety-five percent of mothers dissolved the tablet in a small amount of water and gave it with a spoon. Only eight caretakers reported problems with zinc administration: either vomiting or refusal to take the tablets. Sixty-four percent of children received the full 14-day course of treatment, and more than 89% of children were given at least a 10-day course of zinc treatment. The levels of correct administration were very good but might be lower under non-research conditions.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Bryce J, Boschi-Pinto C, Shibuya K, Black RE, 2005. WHO estimates of the causes of death in children. Lancet 365 : 1147–1152. [Google Scholar]
  2. Baqui AH, Black RE, El Arifeen S, Yunus M, Chakraborty J, Ahmed S, Vaughan JP, 2002. Effect of zinc supplementation started during diarrhoea on morbidity and mortality in Bangladeshi children: community randomised trial. BMJ 325 : 1059. [Google Scholar]
  3. Bhutta ZA, Bird SM, Black RE, Brown KH, Gardner JM, Hidayat A, Khatun F, Martorell R, Ninh NX, Penny ME, Rosado JL, Roy SK, Ruel M, Sazawal S, Shankar A, 2000. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr 72 : 1516–1522. [Google Scholar]
  4. Fontaine O, 2001. Effect of zinc supplementation on clinical course of acute diarrhoea. J Health Popul Nutr 19 : 339–346. [Google Scholar]
  5. WHO/UNICEF, 2004. Joint Statement: Clinical Management of Acute Diarrhoea (WHO/FCH/CAH/04.07). Geneva, Switzerland: World Health Organization.
  6. Krause G, Borchert M, Benzler J, Diesfeld HJ, 2000. From diagnosis to drug taking: staff compliance with guidelines and patient compliance to prescriptions in Burkina Faso. Int J Qual Health Care 12 : 25–30. [Google Scholar]
  7. Djimde A, Plowe CV, Diop S, Dicko A, Wellems TE, Doumbo O, 1998. Use of antimalarial drugs in Mali: policy versus reality. Am J Trop Med Hyg 59 : 376–379. [Google Scholar]
  8. Nshakira N, Kristensen M, Ssali F, Whyte SR, 2002. Appropriate treatment of malaria? Use of antimalarial drugs for children’s fevers in district medical units, drug shops and homes in eastern Uganda. Trop Med Int Health 7 : 309–316. [Google Scholar]
  9. Winch PJ, Bagayoko A, Diawara A, Kane M, Thiero F, Gilroy K, Daou Z, Berthe Z, Swedberg E, 2003. Increases in correct administration of chloroquine in the home and referral of sick children to health facilities through a community-based intervention in Bougouni District, Mali. Trans R Soc Trop Med Hyg 97 : 481–490. [Google Scholar]
  10. World Health Organization/United Nations Children’s Fund, 2004. Joint Statement: Clinical Management of Acute Diarrhoea, WHO/FCH/CAH/04.07 or UNICEF/PD/Diarrhoea/01. Geneva, Switzerland: World Health Organization.
  11. SPSS, 2000. Statistical Program for the Social Sciences (SPSS), Version 11. Chicago, IL: SPSS.
  12. STATA, 2000. Stata Statistical Software: Release 7.0. College Station, TX: Stata Corp..
  13. Qingjun L, Jihui D, Laiyi T, Xiangjun Z, Jun L, Hay A, Shires S, Navaratnam V, 1998. The effect of drug packaging on patients’ compliance with treatment for Plasmodium vivax malaria in China. Bull World Health Organ 76 (suppl 1): 21–27. [Google Scholar]
  14. Yeboah-Antwi K, Gyapong JO, Asare IK, Barnish G, Evans DB, Adjei S, 2001. Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment. Bull World Health Organ 79 : 394–399. [Google Scholar]
  15. Sirima SB, Konate A, Tiono AB, Convelbo N, Cousens S, Pagnoni F, 2003. Early treatment of childhood fevers with pre-packaged antimalarial drugs in the home reduces severe malaria morbidity in Burkina Faso. Trop Med Int Health 8 : 133–139. [Google Scholar]
  16. Pagnoni F, Convelbo N, Tiendrebeogo J, Cousens S, Esposito F, 1997. A community-based programme to provide prompt and adequate treatment of presumptive malaria in children. Trans R Soc Trop Med Hyg 91 : 512–517. [Google Scholar]
  17. Ngoh LN, Shepherd MD, 1997. Design, development, and evaluation of visual aids for communicating prescription drug instructions to nonliterate patients in rural Cameroon. Patient Educ Couns 30 : 257–270. [Google Scholar]
  18. Agyepong IA, Ansah E, Gyapong M, Adjei S, Barnish G, Evans D, 2002. Strategies to improve adherence to recommended chloroquine treatment regimes: a quasi-experiment in the context of integrated primary health care delivery in Ghana. Soc Sci Med 55 : 2215–2226. [Google Scholar]
  19. Ansah EK, Gyapong JO, Agyepong IA, Evans DB, 2001. Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup. Trop Med Int Health 6 : 496–504. [Google Scholar]
  20. Gomes M, Wayling S, Pang L, 1998. Interventions to improve the use of antimalarials in south-east Asia: an overview. Bull World Health Organ 76 (suppl 1): 9–19. [Google Scholar]

Data & Media loading...

  • Received : 19 Jul 2005
  • Accepted : 19 Nov 2005

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error